| Issue |
Section |
Title |
File |
| Vol 84, No 2 (2012) |
Editorial |
Clinicopathogenetic variants of anemia in patients with intestinal inflammation |
|
| Vol 90, No 3 (2018) |
Editorial |
Stem Cell Therapy for Perianal Crohn’s Disease |
(Rus)
|
| Vol 90, No 6 (2018) |
Editorial |
Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice |
(Rus)
|
| Vol 90, No 2 (2018) |
Editorial |
Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy |
(Rus)
|
| Vol 91, No 2 (2019) |
Editorial |
Celiac disease associated with ulcerative colitis |
(Rus)
|
| Vol 91, No 8 (2019) |
Editorial |
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation |
(Rus)
|
| Vol 93, No 2 (2021) |
Original articles |
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars |
(Rus)
|
| Vol 93, No 12 (2021) |
Original articles |
Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy |
(Rus)
|
| Vol 94, No 2 (2022) |
Original articles |
Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases |
(Rus)
|
| Vol 97, No 2 (2025): Вопросы гастроэнтерологии |
Original articles |
Prevention of venous thromboembolic complications in patients with ulcerative colitis |
(Rus)
|
